Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sonja Zafirovic has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    OBESITY-INDUCED HYPERLEPTINEMIA CONTRIBUTES TO METABOLIC AND INFLAMMATORY ALTERATIONS IN RAT SERUM

    by Milan Obradović, Katarina Banjac, Sonja Zafirović, Esma Isenović

    Obesity is associated with elevated levels of leptin in circulation, which is linked to serious metabolic disorders. This research aimed to investigate the link between concentrations of circulating leptin and metabolic, inflammatory, and oxidative stress markers in high-fat (HF) diet-induced obese rats. We found that consuming a HF diet significantly increased concentrations of leptin (p<0.05), total cholesterol (p<0.05), and interleukin-1 (p<0.01), while decreased concentration of glutathione reductase, but not significantly, in the serum of rats. These findings indicate that hyperleptinemia induced by the HF diet contributes to metabolic and inflammatory disturbance in obese rats.

  • Open Access

    Estradiol-to-oocyte ratio as a prognostic biomarker of assisted reproductive outcomes in women with polycystic ovary syndrome: The impact of LH activity

    by Bojana Salovic, Ivan Soldatovic, Aleksandar Stojsavljevic, Svetlana Dragojevic Dikic, Ana Nikolic, Vladimir Gerginic, Sonja Zafirovic, Esma R. Isenovic, Milan Perovic

    Background: Estradiol-to-oocyte ratio (EOR) was proposed as an assisted reproductive technology (ART) outcome predictor in general population. In women with polycystic ovary syndrome (PCOS), hormonal imbalances, especially estradiol and luteinizing hormone (LH) may affect the predictive value of EOR. Objectives: We hypothesized that EOR plays a specific predictive role in PCOS and LH activity during ovarian stimulation modulates EOR and ART outcomes. Design: Retrospective cross-sectional design. Methods: The study included 276 patients with PCOS undergoing ART, stratified into four EOR groups: I (886). Additionally, patients were categorized based on LH activity during ovarian stimulation: no LH, recombinant LH, or LH-like activity. Key-outcome variables included counts of periovulatory follicles, retrieved oocytes, metaphase II (MII) oocytes, total number of embryos, good-quality (GQ) and frozen embryos, biochemical pregnancy rate (BPR), and clinical pregnancy rate (CPR). Comparisons were made across EOR and LH activity groups. Results: Group I (lowest EOR) demonstrated the highest counts of MII oocytes, total number of embryos, GQ and frozen embryos. BPR and CPR showed a decreasing trend with increasing EOR, peaking in Group I. Multivariable analysis identified the absence of LH activity, higher periovulatory follicle count, and lower EOR as independent predictors of improved ART outcomes. The lowest EOR was observed in patients without LH supplementation, who achieved the best clinical results, though the differences between BPR and CPR were not statistically significant. Conclusion: EOR is a valuable prognostic biomarker for ART outcomes in PCOS patients. Lower EOR is associated with more favorable outcomes. LH activity during stimulation influences EOR and ART success, particularly in patients with PCOS.


  • Open Access

    Restoring leptin sensitivity in metabolic and extra-metabolic leptin resistance: Pharmacologic strategies, systemic implications, and future directions

    by Milan Obradovic, Sara Khodahemmati, Sonja Zafirovic, Esma R. Isenovic

    The presence of leptin resistance is a key barrier to the successful management of obesity. The most recent study has focused on pharmacological drugs that are associated with inflammation and endoplasmic reticulum stress, as well as inhibitors of negative regulators, including PTP1B, SOCS3, and HDAC6, and substances that affect the mTOR and cAMP/Epac/Rap1 signaling pathways. Having an understanding that leptin resistance is caused by defective leptin signaling pathways, such as a disruption in the JAK–STAT pathway or an increase in the expression of SOCS3, shows the difficulty of restoring sensitivity. The physiological implications of leptin resistance extend beyond the regulation of metabolism and can influence the cardiovascular system, the liver (NAFLD/MASLD), the immunological system, the inflammatory system, reproductive health and the neuroendocrine system. The fact that leptin has metabolic impacts on various systems highlights the importance of taking an integrated strategy to treatment procedures. Within the context of metabolic and extra-metabolic leptin resistance, this review provides a summary of recent literature evidence pertaining to the restoration of leptin responsiveness. Also, we include a discussion regarding pharmacologic strategies, systemic implications, and future directions.


  • Open Access

    Hyperbaric oxygen therapy: a new frontier in cellular protection for type 2 diabetes

    by Sonja Zafirovic, Milan Obradovic, Esma R. Isenovic

    Diabetes mellitus is one of the biggest public health issues of modern society, with a constant increase in prevalence. It is a complex metabolic disorder characterized by hyperglycemia, dyslipidemia, and impaired insulin signaling, leading to redox imbalance and, consequently, blood vessel dysfunction. One of the key factors in the regulation of vascular tone and contractility is the sodium/potassium adenosine triphosphatase (Na+/K+-ATPase), whose reduced expression and altered activity contribute to the development of vascular dysfunction in type 2 diabetes (T2D). Impaired redox balance and increased production of reactive oxygen species, which directly affect Na+/K+-ATPase activity, also affect the telomere-telomerase system, leading to telomere shortening, DNA damage, and cell apoptosis. Hyperbaric oxygen therapy is used to treat ischemic lesions and vascular complications of diabetes, but the molecular mechanisms underlying its effects on Na+/K+-ATPase and telomere length in T2D patients remain incompletely elucidated.

  • Open Access

    Mitochondrial dysfunction, reactive oxygen species, and diabetes mellitus – A triangular relationship: A review

    by Mia Manojlovic, Sonja Zafirovic, Dragana Tomic Naglic, Edita Stokic, Manfredi Rizzo, Jasjit S. Suri, Esma Isenovic

    Diabetes mellitus (DM) disrupts cellular homeostasis and is characterized by mitochondrial structural and functional impairments similar to those found in other metabolic disorders. Mitochondrial dysfunction (MD) leads to the excessive production of reactive oxygen species (ROS), which are central to the progression of cardiovascular (CV) disease—the leading cause of mortality associated with DM. ROS-driven oxidative stress (OS) is implicated in cardiac injury in both clinical and experimental contexts. This review synthesizes recent literature on the role of MD in the development and progression of DM and its associated CV complications, highlighting disrupted pathways that regulate the balance between ROS production and antioxidant defenses. We summarize alterations in mitochondrial dynamics—including fusion, fission, and mitophagy—mtDNA damage, and impaired oxidative phosphorylation characterized by dysregulated mitochondrial membrane potential (ΔΨm), electron transport chain (ETC) defects, uncoupling, and substrate overload. Additionally, we discuss hyperglycemia-activated pathways such as polyol flux, AGE–RAGE interactions, protein kinase C/nicotinamide adenine dinucleotide phosphate (PKC/NADPH) oxidase activation, and poly(ADP-ribose) polymerase 1 (PARP-1)-mediated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibition, which contribute to inflammation, endothelial dysfunction, β-cell failure, insulin resistance, and micro/macrovascular injury. Diagnostic and biomarker strategies encompass mtDNA analysis, bioenergetic assays, metabolomics, proteomics, and imaging techniques including PET, MRI, and NIRS. Therapeutic approaches aimed at restoring mitochondrial function and mitigating OS include mitochondria-targeted antioxidants (such as MitoQ, CoQ10, SkQ1, SS-31, and Mito-TEMPO), metabolic drugs (including metformin and SGLT2 inhibitors), lifestyle modifications, and emerging gene-editing technologies. The interplay between mitochondria, ROS, and DM reflects a tightly regulated aspect of cellular physiology; while targeted and personalized strategies hold promise, they necessitate rigorous evaluation.


  • Open Access

    Correlation between blood cell indices and adiponectin and leptin levels in COVID-19

    by Mia Manojlovic, Branislava Ilincic, Marko Bojovic, Ivor Kolarski, Dragana Tomic Naglic, Edita Stokic, Sonja Zafirovic, Esma R. Isenovic

    Adipose tissue (AT) is a major metabolic organ, functioning through autocrine, paracrine, and endocrine mechanisms. This study investigated the relationship between adipokine levels and blood cell indices, particularly platelets, in individuals with COVID-19. Another aim was to enhance the understanding of AT's endocrine function during dynamic pathological changes, such as acute viral infections like COVID-19. The study was conducted as a cross-sectional analysis at the University Clinical Center of Vojvodina in 2021 and 2022, including 76 consecutive SARS-CoV-2-positive patients of both sexes. Study parameters were determined from peripheral venous blood samples routinely collected upon hospital admission. The results showed that leptin levels were significantly positively correlated with body mass index (BMI) (ρ = 0.421, P < 0.001) and body fat mass (BFM) (ρ = 0.547, P < 0.001). Simultaneously, a significant negative correlation was observed between adiponectin levels and BMI (ρ = −0.430, P < 0.001). Additionally, a significant positive correlation was found between leptin levels and mean platelet volume (MPV) (ρ = 0.307, P < 0.05), platelet distribution width (PDW) (ρ = 0.325, P < 0.05), and platelet-large cell ratio (P-LCR) (ρ = 0.305, P < 0.05). Leptin's impact on platelet indices was confirmed in both simple and multiple linear regression models, where leptin exhibited a slightly higher beta coefficient than BMI. In contrast, adiponectin levels were negatively correlated with hematocrit (HCT) (ρ = −0.329, P < 0.05). These findings may provide further insight into the previously suspected role of AT in the complex cascade of COVID-19 pathogenesis and platelet activation.


  • The involvement of Akt, mTOR, and S6K in the in vivo effect of IGF-1 on the regulation of rat cardiac Na+/K+-ATPase

    by Katarina Banjac, Milan Obradovic, Sonja Zafirovic, Magbubah Essack, Zoran Gluvic, Milos Sunderic, Olgica Nedic, Esma R. Isenovic

    Background We previously demonstrated that insulin-like growth factor-1 (IGF-1) regulates sodium/potassium adenosine triphosphatase (Na+/K+-ATPase) in vascular smooth muscle cells (VSMC) via phosphatidylinositol-3 kinase (PI3K). Taking into account that others’ work show that IGF-1 activates the PI3K/protein kinase B (Akt) signaling pathway in many different cells, we here further questioned if the Akt/mammalian target of rapamycin (mTOR)/ribosomal protein p70 S6 kinase (S6K) pathway stimulates Na+/K+-ATPase, an essential protein for maintaining normal heart function. Methods and results There were 14 adult male Wistar rats, half of whom received bolus injections of IGF-1 (50 μg/kg) for 24 h. We evaluated cardiac Na+/K+-ATPase expression, activity, and serum IGF-1 levels. Additionally, we examined the phosphorylated forms of the following proteins: insulin receptor substrate (IRS), phosphoinositide-dependent kinase-1 (PDK-1), Akt, mTOR, S6K, and α subunit of Na+/K+-ATPase. Additionally, the mRNA expression of the Na+/K+-ATPase α1 subunit was evaluated. Treatment with IGF-1 increases levels of serum IGF-1 and stimulates Na+/K+-ATPase activity, phosphorylation of α subunit of Na+/K+-ATPase on Ser23, and protein expression of α2 subunit. Furthermore, IGF-1 treatment increased phosphorylation of IRS-1 on Tyr1222, Akt on Ser473, PDK-1 on Ser241, mTOR on Ser2481 and Ser2448, and S6K on Thr421/Ser424. The concentration of IGF-1 in serum positively correlates with Na+/K+-ATPase activity and the phosphorylated form of mTOR (Ser2448), while Na+/K+-ATPase activity positively correlates with the phosphorylated form of IRS-1 (Tyr1222) and mTOR (Ser2448). Conclusion These results indicate that the Akt/mTOR/S6K signalling pathway may be involved in the IGF-1 regulating cardiac Na+/K+-ATPase expression and activity.


  • Open Access

    Insulin-like growth factor-1 reduces cardiac autosis through decreasing AMPK/FOXO1 signaling and Na+/K+-ATPase-Beclin-1 interaction

    by Katarina Banjac, Milan Obradovic, Sonja Zafirovic, Esma R. Isenovic

    Introduction: Insulin-like growth factor-1 (IGF-1) promotes survival and inhibits cardiac autophagy disruption.Methods: Male Wistar rats were treated with IGF-1 (50 µg/kg), and 24 h after injection hearts were excised. The level of interaction between Beclin-1 and the α1 subunit of sodium/potassium-adenosine triphosphates (Na+/K+-ATPase), and phosphorylated forms of IGF-1 receptor/insulin receptor (IGF-1R/IR), forkhead box protein O1 (FOXO1) and AMP-activated protein kinase (AMPK) were measured.Results: The results indicate that IGF-1 decreased Beclin-1’s association with Na+/K+-ATPase (p < 0.05), increased IGF-1R/IR and FOXO1 phosphorylation (p < 0.05), and decreased AMPK phosphorylation (p < 0.01) in rats’ hearts.Conclusions: The new IGF-1 therapy may control autosis and minimize cardiomyocyte mortality.


  • Open Access

    Subacute thyroiditis following COVID-19 vaccination: Case presentation

    by Aleksandra Z Tomic, Sonja S Zafirovic, Zoran M Gluvic, Vladimir S Samardzic, Mirjana T Macvanin, Maja Lj Radunovic, Esma R Isenovic

    Background: Subacute thyroiditis (SAT) is an organ-specific disease that various drugs, including COVID-19 vaccines, can trigger. COVID-19 infection has been associated with thyroid gland damage and disease SARS-CoV-2 direct action, euthyroid sick syndrome, and immune-mediated mechanisms are all potential mechanisms of thyroid damage. It denotes thyroid gland inflammation, most commonly of viral origin, and belongs to the transitory, self-limiting thyroid gland diseases group, causing complications in approximately 15% of patients in the form of permanent hypothyroidism. Some authors say SAT is the most common thyroid disease associated with COVID-19. Purpose: The occurrence of SAT many weeks after administering the second COVID-19 vaccine is rare and has limited documentation in academic literature. This study aims to present the occurrence of SAT after administering the COVID-19 vaccine. We present the case of a 37-year-old man who developed SAT 23 days after receiving the second dose of Pfizer BioNTech's COVID-19 mRNA vaccine. Research design and study sample: Due to neck pain and an elevated body temperature (up to 38.2°C), a 37-year-old male subject presented for examination 23 days after receiving the second Pfizer BioNTech mRNA vaccine against SARS-CoV-2 viral infection. The patient denied ever having an autoimmune disease or any other disease. Painful neck palpation and a firm, slightly enlarged thyroid gland with no surrounding lymphadenopathy were identified during the exam. The heart rate was 104 beats per minute. All of the remaining physical findings were normal. Data collection and/or Analysis: Data collected during the disease are integral to the medical record. Results: Hematology and biochemistry analyses at the initial and follow-up visits revealed minor leukocytosis, normocytic anaemia, and thrombocytosis, followed by a mild increase in lactate dehydrogenase and decreased iron levels. The patient's thyroid function and morphology had recovered entirely from post-vaccine SAT. Conclusions: Results from this study emphasise the need for healthcare professionals to promptly report any case of SAT related to COVID-19 vaccination. Further investigation is warranted to understand the immunopathogenesis of COVID-19-associated thyroiditis and the impact of COVID-19 immunization on this condition.